Every 4 minutes, one person is diagnosed with a blood cancer
Every 10 minutes, someone dies from a blood cancer
80 diseases are FDA approved for routine treatment with cord blood stem cells
1 in 3 people may benefit from stem cell regenerative medicine therapy
Approximately 1 in every 400 children and adolescents are diagnosed with diabetes and about 10,000 babies per year in the U.S. will develop cerebral palsy. Leukemia, lymphoma and myeloma will cause the deaths of an estimated 54,020 people in the U.S. this year.1
For the diseases listed above, and many others, stem cell therapies offer the greatest potential for a cure. Privately banking your baby's umbilical cord blood and cord tissue stem cells ensures that this precious resource will be readily available should a stem cell transplant be needed to save a family member’s life.
In 1988, the first successful cord blood transplant occurred for the treatment of Fanconi Anemia. At that time it was the only disease known that could be effectively treated with cord blood stem cells.
Eleven years later in 1999, a second disease was added to the list of FDA approved therapies using cord blood stem cells. Today, that list has exploded to include over 80 diseases and conditions, many of which were previously considered incurable.
With over 700 clinical trials and numerous research studies currently in progress, it is estimated that as many as 1 in 3 people in the United States may benefit from regenerative medicine therapy with stem cells.2
1 The Leukemia & Lymphoma Society. (August 19, 2010). Facts & Statistics. Retrieved September 2, 2010, from http://www.leukemia-lymphoma.org/all_page?item_id=12486
2 Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008;4:269-274. Epub August 5, 2008.
As many as 1 in 3 people in the U.S. may benefit from stem cell regenerative medicine therapy.